Luminate Medical

Luminate Medical

Private
IrelandHealthcare & Life Scienceshttps://www.luminatemed.com

Last Round

Series A

Jan 7, 2026

Est. Valuation

$75M

Total Funding Raised

$51.81M

Momentum Score

50 /100

Company Overview

Luminate Medical is a clinical-stage medical device company, spun out from the University of Galway, that develops technologies to prevent and control the side effects of cancer treatment. The company's mission is to improve the quality of life for cancer patients undergoing chemotherapy. Its product portfolio includes the 'Lily' device, a portable, wearable cap designed to prevent chemotherapy-induced hair loss, and the 'Lilac' system, which consists of gloves and boots to prevent peripheral nerve damage. Luminate Medical is venture-backed and has raised significant capital, including a $17.5 million Series A round in late 2024, to fund clinical trials in the United States and prepare for market launch.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Telemedicine, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

wearable medical devicechemo hair losscompression therapysupportive oncologyscalp compressionchemotherapy-induced peripheral neuropathynerve damage from chemoat-home cancer carescalp cooling alternativeCIPNchemotherapy-induced alopeciahome infusioncold capHealth IoT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Luminate Medical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Luminate Medical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJan 7, 2026
Series A ExtensionDec 4, 2024
Series ASep 19, 2024
GrantJun 20, 2023
SeedMay 30, 2022
Accelerator
Aug 30, 2021

Key People

Founding team and executive leadership

Barbara Oliveira

Co-Founder Chief Clinical Officer

Founding Team

Aaron Hannon

CEO Co-Founder

Founding Team

Conor Macken

Chief Financial Officer

Executive Team

Luminate Medical Investors

Notable investors and investment history

InvestorRounds
Atlantic Bridge CapitalSeries A
European Innovation CouncilGrant
ARTIS VenturesSeries A
Y CombinatorSeries A, Accelerator
Faber VenturesSeries A
ElkstoneSeries A
8VCSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 23, 2026

    Grew 16% QoQ from 51 to 59 employees.

  • Jan 8, 2026

    Plans to create 130 new jobs in Galway.

Luminate Medical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Luminate Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Luminate Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersIreland
Employee Range59
Year Founded2018
Last FundingJan 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.